6594 POSTER First-line bevacizumab in combination with chemotherapy in the treatment of patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): an open-label safety study (MO19390).

Details

Language :

English

ISSN :

13596349

Volume :

5

Issue :

4

Database :

Supplemental Index

Journal :

EJC Supplements

Publication Type :

Academic Journal

Accession number :

27457522

Full Text :

https://doi.org/10.1016/S1359-6349(07)71422-2